Angela Märten Selected Research

reversin 121

1/2008

Effects of the high-affinity Peptide reversin 121 on multidrug resistance proteins in experimental pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela Märten Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 12/2002
23	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015 - 12/2003
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2014
11	Adenocarcinoma 02/2010 - 12/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 02/2006 - 12/2002
3	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2015
3	Disease Progression 07/2021 - 02/2006
2	Exanthema (Rash) 01/2018 - 08/2014
1	Body Weight (Weight, Body) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Cough 01/2018
1	Diarrhea 01/2018
1	Dyspnea (Shortness of Breath) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Pain (Aches) 01/2018
1	Acne Vulgaris 01/2018
1	Stomatitis 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Multiple Myeloma 06/2010
1	Cachexia 11/2009
1	Hypoxia (Hypoxemia) 11/2008
1	Colonic Neoplasms (Colon Cancer) 02/2008
1	Pathologic Neovascularization 01/2008
1	Liver Neoplasms (Liver Cancer) 05/2006
1	Hepatocellular Carcinoma (Hepatoma) 04/2006
1	Leukemia 01/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2004
1	Hypersensitivity (Allergy) 03/2003

Drug/Important Bio-Agent (IBA)

16	AfatinibIBA 01/2022 - 10/2014
10	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2015
7	Interferon-alpha (Interferon Alfa)IBA 09/2008 - 08/2004
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2015
5	Gemcitabine FDA Link 01/2018 - 08/2004
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2015 - 01/2010
5	AntigensIBA 05/2007 - 01/2004
4	osimertinibIBA 12/2021 - 11/2018
3	Gefitinib (Iressa)FDA Link 06/2019 - 10/2014
3	Pharmaceutical PreparationsIBA 07/2015 - 05/2007
3	Capecitabine (Xeloda)FDA Link 07/2015 - 01/2010
3	Fluorouracil (Carac)FDA LinkGeneric 04/2012 - 11/2006
3	InterferonsIBA 04/2012 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 02/2010 - 01/2004
3	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2006 - 01/2004
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 11/2006
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 04/2012
2	LigandsIBA 04/2012 - 06/2010
2	Complement C3b (C3bi)IBA 02/2010 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008 - 01/2008
2	Subfamily B ATP Binding Cassette TransporterIBA 05/2008 - 01/2008
2	Peptides (Polypeptides)IBA 01/2008 - 01/2004
2	AntibodiesIBA 11/2006 - 05/2006
1	PlatinumIBA 01/2019
1	thiamine triphosphorate (TTP)IBA 01/2019
1	Biological ProductsIBA 07/2015
1	Cytostatic AgentsIBA 05/2013
1	AutoantibodiesIBA 02/2010
1	Complement System Proteins (Complement)IBA 02/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2009
1	Bortezomib (Velcade)FDA Link 11/2008
1	Proteasome InhibitorsIBA 11/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2008
1	Small Interfering RNA (siRNA)IBA 02/2008
1	LipidsIBA 02/2008
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2008
1	Coloring Agents (Dyes)IBA 01/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	reversin 121IBA 01/2008
1	Diphosphonates (Bisphosphonates)IBA 05/2007
1	Zoledronic Acid (Zometa)FDA Link 05/2007
1	micaIBA 11/2006
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2006
1	Fetal Proteins (Fetoprotein)IBA 04/2006
1	CytokinesIBA 04/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2006
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2006
1	Interleukin-10 (Interleukin 10)IBA 11/2004
1	Antineoplastic Agents (Antineoplastics)IBA 12/2003
1	RNA (Ribonucleic Acid)IBA 12/2003
1	Interferon-gamma (Interferon, gamma)IBA 03/2003
1	VaccinesIBA 12/2002

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2019 - 08/2004
11	Therapeutics 01/2019 - 01/2004
5	Time-to-Treatment 09/2019 - 01/2015
5	Immunotherapy 06/2008 - 04/2003
4	Chemoradiotherapy 09/2008 - 11/2006
2	Radiotherapy 07/2009 - 05/2008
1	Drug Tapering 01/2019
1	Parenteral Nutrition 11/2009
1	Hematopoietic Stem Cell Transplantation 04/2003
1	Transplantation 04/2003
1	Bone Marrow Purging 04/2003
1	Aftercare (After-Treatment) 03/2003